Physician profile
Sunil Chandy
NPI 1720375793
$11,733.88
in general payments reported to CMS, 2019-2025
50 companies · $1,774 in 2025
The $1,774 reported for 2025 was more than what 80% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,731 · 2020: $1,295 · 2021: $1,549 · 2022: $2,086 · 2023: $1,559 · 2024: $1,742 · 2025: $1,774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,073.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,462.04 | 2019-2025 | Relistor |
| Nevro Corp. | $1,108.91 | 2019-2024 | Senza |
| Abbvie INC. | $888.93 | 2021-2025 | Qulipta, Ubrelvy |
| Boston Scientific Corporation | $854.75 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $799.62 | 2019-2025 | Ztlido |
| Pfizer INC. | $751.93 | 2019-2025 | |
| Amgen INC. | $606.15 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $595.84 | 2019-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $492.40 | 2019-2025 | Proclaim, Eterna |
| Averitas Pharma INC. | $307.00 | 2023-2025 | Qutenza |
| Ibsa Pharma INC. | $301.10 | 2020-2025 | Tirosint, Tirosint, Licart |
| Impel Pharmaceuticals INC. | $281.59 | 2022-2023 | Trudhesa |
| Arbor Pharmaceuticals, INC. | $258.90 | 2019-2022 | |
| Valinor Pharma, LLC | $205.62 | 2023-2025 | Movantik |
| Biohaven Pharmaceutical Holding Company Ltd. | $204.46 | 2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Chandy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.